CryoLogyx is an early-stage biotechnology business that develops frozen, ready-to-use cells for drug discovery.
CryoLogyx has raised $636K in total funding. The most recent round was Seed. The last funding was announced in March 2024.
CryoLogyx's investors include Innovate UK, Oxford University Innovation, Oxford Technology Management.
CryoLogyx is headquartered in Coventry, United Kingdom.
CryoLogyx is an early-stage biotechnology business that develops frozen, ready-to-use cells for drug discovery.
CryoLogyx is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CryoLogyx — Funding & Investors." VCBacked, March 18, 2024, https://www.vcbacked.co/company/cryologyx. Accessed August 15, 2026.
VCBacked. (2024). CryoLogyx — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/cryologyx
{{cite web |title=CryoLogyx — Funding & Investors |url=https://www.vcbacked.co/company/cryologyx |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated